BioKarl Nägler joined Gimv in 2011.Having started his professional career in 2002 at Atlas Venture in London and Munich, he later joined Ventech, a Paris-based venture capital firm focused on Europe and China.Karl has a successful track record in early and later stage Life Science investing and was instrumental in the formation, financing and/or exit of several start-ups across Europe, including U3 Pharma (acquired by ....
Access "Karl Nägler" Work Experience (Current/Past), Board Seats, Joined Date, Contact Details - Emailid/Phone and Investments (If any)
in one connected platform (AcquityData).
We use essential cookies to run this site (like keeping you signed in), and — only with your consent — analytics cookies to understand how the site is used. See our
Privacy Policy for details on what we collect and why.